Catalyst Wire Dossier Catalyst Wire Dossier

NN-220

somatropin · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NN-220, covering 2019-10-14 to 2019-10-14. Get the full timeline:

Most recent: Clinical Trial Update: Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome [Phase 3]

See pricing